Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01307293 · ClinicalTrials.gov registry record · NA

Prevention of Postpartum Traumatic Stress (PTSD) in Mothers With Preterm Infants.

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
110
Enrollment target

NCT01307293: Completed NA study, sponsored by Stanford University.

NCT01307293 is a NA study that has completed, run by Stanford University. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01307293, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target

Study Summary

The purpose of the study includes: 1. To develop a treatment manual and pilot test this treatment intervention which is designed to prevent and reduce psychological distress in parents who have infants hospitalized in the neonatal intensive care unit (NICU). 2. To conduct a treatment intervention study in which parents of NICU infants will receive a 6-12 session treatment designed to reduce psychological distress, and to compare outcomes with parents who do not receive the intervention. We hope to learn whether or not a simple psychotherapeutic and psychoeducational intervention offered to parents of NICU infants can prevent or minimize the development of symptoms of psychological distress in parents, including symptoms of anxiety and depression and posttraumatic stress disorder (PTSD).

Interventions

  • BEHAVIORAL Cognitive behavior therapy

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2011-04
Est. Completion 2014-06
Phase NA
Stanford University

1,744 total trials

What the finished NCT01307293 record still lists

NCT01307293 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Cognitive behavior therapy is the first listed.

NCT01307293 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01307293 about?

NCT01307293 is a clinical study titled "Prevention of Postpartum Traumatic Stress (PTSD) in Mothers With Preterm Infants.". The purpose of the study includes: 1. To develop a treatment manual and pilot test this treatment intervention which is designed to prevent and reduce psychological distress in parents who have infants hospitalized in the neonatal intensive care unit (NICU). 2. To conduct a treatment intervention s...

What is the current status of trial NCT01307293?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2011-04. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01307293?

The interventions under investigation include: Cognitive behavior therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01307293?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01307293's enrollment target sits among peer trials

110 816th of 2000 higher than 1,176 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01307293, the US trial registry maintained by the National Library of Medicine. NCT01307293 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.